Envestnet Portfolio Solutions Inc. Cuts Position in The Clorox Company $CLX

Envestnet Portfolio Solutions Inc. decreased its holdings in The Clorox Company (NYSE:CLX) by 77.6% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,475 shares of the company’s stock after selling 22,441 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Clorox were worth $778,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the business. Simplicity Wealth LLC boosted its stake in shares of Clorox by 157.3% during the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after acquiring an additional 11,198 shares during the last quarter. Raymond James Financial Inc. boosted its stake in shares of Clorox by 15.6% during the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock valued at $39,747,000 after acquiring an additional 36,352 shares during the last quarter. OneDigital Investment Advisors LLC purchased a new position in Clorox during the first quarter worth about $247,000. Cornerstone Wealth Group LLC lifted its position in Clorox by 19.0% during the first quarter. Cornerstone Wealth Group LLC now owns 25,582 shares of the company’s stock worth $3,767,000 after buying an additional 4,085 shares during the period. Finally, Alpine Bank Wealth Management purchased a new position in Clorox during the first quarter worth about $478,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Activity

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.63% of the stock is currently owned by corporate insiders.

Clorox Stock Up 1.8%

CLX opened at $119.73 on Monday. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The stock’s fifty day moving average is $121.61 and its 200-day moving average is $127.58. The company has a market capitalization of $14.58 billion, a PE ratio of 18.36, a P/E/G ratio of 0.99 and a beta of 0.52.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s payout ratio is currently 76.07%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on CLX shares. BNP Paribas Exane cut their price objective on Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a report on Friday. Citigroup cut their price objective on Clorox from $135.00 to $130.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. Morgan Stanley cut their price objective on Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a report on Friday, August 1st. Wells Fargo & Company dropped their target price on Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a report on Thursday, September 25th. Finally, UBS Group dropped their target price on Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, Clorox presently has a consensus rating of “Reduce” and an average price target of $130.20.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.